About EXIAS Medical
Advancing Electrolyte Diagnostics through Innovation
EXIAS Medical is an Austrian medical technology company dedicated to developing next-generation in vitro diagnostic (IVD) solutions for clinical laboratories and point-of-care testing. Specializing in electrolyte analysis, the company is committed to delivering high-performance diagnostic systems that combine precision, reliability, and ease of use, enabling healthcare professionals to make faster and more informed clinical decisions.
Established in 2014 and headquartered in Graz, Austria, EXIAS Medical designs and manufactures all of its products in-house under internationally recognized quality standards. The company is ISO 13485 certified, and its diagnostic systems comply with the European In Vitro Diagnostic Regulation (IVDR 2017/746), demonstrating its commitment to quality, safety, and regulatory excellence.
Drawing on decades of expertise inherited from the legacy of AVL Medical, EXIAS Medical combines deep industry knowledge with a forward-thinking approach to innovation. Its flagship solutions, including the EXIAS e|1 Electrolyte Analyzer and EXIAS m|1 Electrolyte Module, are designed to streamline laboratory workflows while delivering fast, accurate, and maintenance-free electrolyte testing for hospitals, laboratories, and critical care environments.
As a trusted partner of Pinecrest Healthcare Ltd., EXIAS Medical brings advanced electrolyte diagnostic solutions to healthcare institutions across Nigeria. Through this partnership, Pinecrest Healthcare provides expert installation; user training, technical support, and dedicated after-sales service, helping laboratories improve efficiency, diagnostic accuracy, and patient care.